News

The VBCF is a proud member of the VCDI - Vienna COVID-19 Diagnostic Initiative

The COVID-19 pandemic poses an enormous threat for healthcare systems and economies in Austria, Europe and the world. In this time of crisis,…

03 Apr'20

SARS-CoV-2, the virus causing coronavirus disease-19 (COVID-19), is spreading worldwide at a fast pace. In a concerted effort including researchers…

03 Apr'20

On March, 21st, 2020, Alwin Köhler was announced as the new Director of the Max Perutz Labs Vienna. He holds a joint Professorship for Molecular…

02 Apr'20

In a new study published in the Journal Science Advances, the Bell lab at IMBA reveals how multiple highly-conserved chromatin modifying complexes…

25 Mar'20

Valneva has successfully completed an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) and agreed on the clinical development…

24 Mar'20

Valneva today provided an update on its operations as the COVID-19 situation evolves.

11 Mar'20

A marvel of complexity, the nucleus is the command center of the cell – harboring information, codes and controlled access. But different from…

08 Mar'20

Valneva announced that the Food and Drug Administration (FDA) has approved the extension of the shelf life of its Japanese encephalitis vaccine IXIARO^…

05 Mar'20

Frameshifts occur when the reading frame in which genetic information is translated is perturbed. Textbook knowledge considers frameshifts to be…

05 Mar'20

The 7th Ubiquitin Symposium will be held at the Vienna BioCenter on 14-15 May 2020. The organisers have put together a program that covers various…

04 Mar'20

The Medical University of Vienna has nominated Selma Osmanagic-Myers as Researcher of the Month March 2020 for her paper „Endothelial progerin…

Vienna COVID-19 Diagnostics Initiative

A Broad Alliance of Viennese Scientists builds COVID-19 Testing Infrastructure

Fighting SARS-CoV-2 in human blood vessel organoids

Alwin Köhler appointed as Scientific Director

Deciphering the epigenetic interplay to safeguard embryonic stem cell identity

Valneva Reports Positive End-of-Phase 2 Chikungunya Meeting with the U.S. FDA; Sets Stage for Phase 3 Study

Valneva Provides Business Update on COVID-19 Situation

Layered Liquids – reaction chambers for gene regulation

Valneva Announces FDA Approval of IXIARO® Shelf Life Extension to 36 Months; New US Military RFP Issued

Frameshifts could be evolutionary shortcuts to create novel proteins

7th Ubiquitin Symposium at the Vienna BioCenter

Selma Osmanagic-Myers is Researcher of the Month at the Medical University of Vienna